Guided Therapeutics GTHP
OTC GTHP
$0.22 +0.00 (+0.00%)
At close: Aug 18, 2026 · 4:00 PM EDT

Guided Therapeutics (GTHP) Net Margin Growth (3y) (2013 - 2025)

Guided Therapeutics (GTHP) Net Margin Growth (3y) (2013 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (3y) (Qtr)
1 Abbott Laboratories 202.72 Bn 197.12 Bn 7.27 Bn -641.00
2 Stryker 126.42 Bn 122.94 Bn 4.50 Bn 459.00
3 Medtronic 119.75 Bn 110.53 Bn 6.41 Bn -108.00
4 Boston Scientific 74.13 Bn 73.60 Bn 3.85 Bn 941.00
5 Edwards Lifesciences 51.78 Bn 47.53 Bn 1.35 Bn -1,024.00
6 Dexcom 35.29 Bn 33.34 Bn 830.00 Mn 574.00
7 GE HealthCare Technologies 33.95 Bn 31.85 Bn 2.18 Bn 216.00
8 Koninklijke Philips 26.22 Bn 22.90 Bn 4.55 Bn 647.00
9 Steris 23.21 Bn 22.73 Bn 684.20 Mn 300.00
10 Guided Therapeutics 21.24 Mn 21.23 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2025 3.38 Mn
Jun 30, 2025 1.94 Mn
Dec 31, 2024 -6.92 Mn
Dec 31, 2023 -994,162.00
Sep 30, 2022 -2.25 Mn
Jun 30, 2022 24.53 Mn
Mar 31, 2022 -1.99 Mn
Dec 31, 2021 569,929.00
Sep 30, 2021 3.76 Mn
Jun 30, 2021 -10.02 Mn
Dec 31, 2020 1.52 Mn
Sep 30, 2020 930,996.00
Dec 31, 2019 633,789.00
Sep 30, 2019 -1.22 Mn
Dec 31, 2018 2.11 Mn
Sep 30, 2018 -365,000.00
Jun 30, 2018 7.22 Mn
Mar 31, 2018 3.42 Mn
Dec 31, 2017 1.80 Mn
Sep 30, 2017 636,212.00